| Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 DA Barbie, P Tamayo, JS Boehm, SY Kim, SE Moody, IF Dunn, ... Nature 462 (7269), 108-112, 2009 | 3172 | 2009 |
| Artificial intelligence in cancer imaging: clinical challenges and applications WL Bi, A Hosny, MB Schabath, ML Giger, NJ Birkbak, A Mehrtash, ... CA: a cancer journal for clinicians 69 (2), 127-157, 2019 | 1399 | 2019 |
| Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets PK Brastianos, SL Carter, S Santagata, DP Cahill, A Taylor-Weiner, ... Cancer discovery 5 (11), 1164-1177, 2015 | 1020 | 2015 |
| CDK8 is a colorectal cancer oncogene that regulates â-catenin activity R Firestein, AJ Bass, SY Kim, IF Dunn, SJ Silver, I Guney, E Freed, ... Nature 455 (7212), 547-551, 2008 | 807 | 2008 |
| Integrative genomic approaches identify IKBKE as a breast cancer oncogene JS Boehm, JJ Zhao, J Yao, SY Kim, R Firestein, IF Dunn, SK Sjostrom, ... Cell 129 (6), 1065-1079, 2007 | 714 | 2007 |
| Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations PK Brastianos, PM Horowitz, S Santagata, RT Jones, A McKenna, G Getz, ... Nature genetics 45 (3), 285-289, 2013 | 686 | 2013 |
| Emerging insights into the molecular and cellular basis of glioblastoma GP Dunn, ML Rinne, J Wykosky, G Genovese, SN Quayle, IF Dunn, ... Genes & development 26 (8), 756-784, 2012 | 670 | 2012 |
| Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study DN Cagney, AM Martin, PJ Catalano, AJ Redig, NU Lin, EQ Lee, PY Wen, ... Neuro-oncology 19 (11), 1511-1521, 2017 | 651 | 2017 |
| Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells C Scholl, S Fröhling, IF Dunn, AC Schinzel, DA Barbie, SY Kim, SJ Silver, ... Cell 137 (5), 821-834, 2009 | 624 | 2009 |
| AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer KM Vasudevan, DA Barbie, MA Davies, R Rabinovsky, CJ McNear, ... Cancer cell 16 (1), 21-32, 2009 | 622 | 2009 |
| Continuous release of endostatin from microencapsulated engineered cells for tumor therapy T Joki, M Machluf, A Atala, J Zhu, NT Seyfried, IF Dunn, T Abe, RS Carroll, ... Nature biotechnology 19 (1), 35-39, 2001 | 484 | 2001 |
| Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas PK Brastianos, A Taylor-Weiner, PE Manley, RT Jones, D Dias-Santagata, ... Nature genetics 46 (2), 161-165, 2014 | 464 | 2014 |
| Treatment for brain metastases: ASCO-SNO-ASTRO guideline MA Vogelbaum, PD Brown, H Messersmith, PK Brastianos, S Burri, ... Neuro-oncology 24 (3), 331-357, 2022 | 378 | 2022 |
| Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors LS Eberlin, I Norton, D Orringer, IF Dunn, X Liu, JL Ide, AK Jarmusch, ... Proceedings of the National Academy of Sciences 110 (5), 1611-1616, 2013 | 336 | 2013 |
| Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs IF Dunn, O Heese, PML Black Journal of neuro-oncology 50, 121-137, 2000 | 332 | 2000 |
| A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo EY Tsai, JV Falvo, AV Tsytsykova, AK Barczak, AM Reimold, LH Glimcher, ... Molecular and cellular biology, 2000 | 330 | 2000 |
| Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery S Santagata, LS Eberlin, I Norton, D Calligaris, DR Feldman, JL Ide, X Liu, ... Proceedings of the National Academy of Sciences 111 (30), 11121-11126, 2014 | 292 | 2014 |
| Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma M Abedalthagafi, WL Bi, AA Aizer, PH Merrill, R Brewster, PK Agarwalla, ... Neuro-oncology 18 (5), 649-655, 2016 | 283 | 2016 |
| Updates in the management of brain metastases ND Arvold, EQ Lee, MP Mehta, K Margolin, BM Alexander, NU Lin, ... Neuro-oncology 18 (8), 1043-1065, 2016 | 247 | 2016 |
| Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM WR Wiedemeyer, IF Dunn, SN Quayle, J Zhang, MG Chheda, GP Dunn, ... Proceedings of the National Academy of Sciences 107 (25), 11501-11506, 2010 | 244 | 2010 |
